Published in Lancet on February 04, 1995
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface (2007) 1.68
Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem (2008) 1.42
Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A (2001) 1.32
EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J Cell Biol (2003) 1.32
Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol (2002) 1.18
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res (2005) 1.16
Regulation of E-cadherin: does hypoxia initiate the metastatic cascade? Mol Pathol (1999) 1.11
Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. J Clin Invest (1998) 1.09
Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol (2005) 1.03
Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. World J Gastroenterol (2005) 0.99
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica (2011) 0.97
Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative. Stroke (2010) 0.97
Protein therapeutics for cardiac regeneration after myocardial infarction. J Cardiovasc Transl Res (2010) 0.97
Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase. Clin Exp Metastasis (1999) 0.96
The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology (2001) 0.93
HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics. Int J Mol Sci (2013) 0.92
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am J Pathol (2001) 0.91
Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis. Clin Exp Metastasis (2000) 0.90
Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Clin Exp Metastasis (2007) 0.89
c-Met modulates RPE migratory response to laser-induced retinal injury. PLoS One (2012) 0.88
Hepatocyte growth factor and clinical diabetes in postmenopausal women. Diabetes Care (2010) 0.88
c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis (2003) 0.87
Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut (2002) 0.87
In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment. Tissue Eng Part B Rev (2013) 0.87
Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation. Pharm Res (2008) 0.86
Ontogeny of hepatocyte growth factor (HGF) and its receptor (c-met) in human placenta: reduced HGF expression in intrauterine growth restriction. Am J Pathol (1998) 0.85
Oxidized low density lipoprotein, stem cells, and atherosclerosis. Lipids Health Dis (2012) 0.85
Production of hepatocyte growth factor during acute myocardial infarction. Heart (2000) 0.84
Role of HGF/c-Met in serum-starved ARPE-19 cells. Korean J Ophthalmol (2007) 0.84
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages. Haematologica (2014) 0.83
Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol Int (2007) 0.83
Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One (2014) 0.81
Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry. Br J Cancer (1998) 0.81
Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. Clin Exp Metastasis (1999) 0.79
Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro. World J Surg Oncol (2012) 0.79
Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications. Clin Exp Nephrol (2015) 0.78
Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J Gastroenterol (2002) 0.78
hSulf-1 inhibits cell proliferation and migration and promotes apoptosis by suppressing stat3 signaling in hepatocellular carcinoma. Oncol Lett (2014) 0.78
The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.78
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion. Stem Cells Dev (2014) 0.77
Fetal growth restriction and hepatocyte growth factor. Arch Dis Child Fetal Neonatal Ed (1997) 0.77
Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative. J Artif Organs (2013) 0.76
Hepatocyte growth factor concentration during the first day of acute coronary syndrome. Arch Med Sci (2012) 0.75
Cardiac Regeneration using Growth Factors: Advances and Challenges. Arq Bras Cardiol (2016) 0.75
Repeated gene transfection impairs the engraftment of transplanted porcine neonatal pancreatic cells. Diabetes Metab J (2011) 0.75
Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor. Oncolytic Virother (2016) 0.75
Hsp90 and hepatobiliary transformation during sea lamprey metamorphosis. BMC Dev Biol (2015) 0.75
The low levels of circulating hepatocyte growth factor in nephrolithiasis cases: independent from gene polymorphism. Urolithiasis (2015) 0.75
Extracellular matrix protein laminin enhances mesenchymal stem cell (MSC) paracrine function through αvβ3/CD61 integrin to reduce cardiomyocyte apoptosis. J Cell Mol Med (2017) 0.75
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14
Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06
Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine (1995) 1.05
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
A binding site for activation by the Bacillus subtilis AhrC protein, a repressor/activator of arginine metabolism. Mol Gen Genet (1995) 1.03
A simple new formula to assess liver weight. Transplant Proc (2003) 0.98
Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res (1999) 0.98
Adult living donor liver transplantation: the hepatologist's perspective. Hepatology (2001) 0.98
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant (2010) 0.98
Dissecting the molecular details of prokaryotic transcriptional control by surface plasmon resonance: the methionine and arginine repressor proteins. Biosens Bioelectron (1998) 0.98
Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer (1998) 0.97
Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis (2010) 0.97
Living related liver transplantation for acute liver failure in children. Liver Transpl Surg (1999) 0.97
Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol (1997) 0.96
Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow. Vet Surg (1995) 0.95
Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95
Infected false aneurysms of the subclavian artery: a complication in drug addicts. J Vasc Surg (1984) 0.94
Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl (2000) 0.92
Hepatic angiomyolipoma: two case reports of caudate-based lesions and review of the literature. Liver Transpl Surg (1997) 0.91
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. J Cell Biochem Suppl (1994) 0.91
An alternative technique for in situ arterial flushing in elderly liver donors with atherosclerotic occlusive disease. Transplantation (1993) 0.91
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation (1997) 0.90
Retransplantation for recurrent hepatitis C. Liver Transpl Surg (1997) 0.90
Liver transplantation in patients beyond age 60. Transplant Proc (1993) 0.89
A decrease in intracellular zinc level precedes the detection of early indicators of apoptosis in HL-60 cells. Apoptosis (2001) 0.89
Use of livers with microvesicular fat safely expands the donor pool. Transplantation (1997) 0.89
Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation (2000) 0.89
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation (1997) 0.88
Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl (2001) 0.87
Enhancing the sexual function of women living with chronic pain: a cognitive-behavioural treatment group. Pain Res Manag (2008) 0.86
The relationship of the axillary nerve to arthroscopically placed capsulolabral sutures. An anatomic study. Am J Sports Med (1998) 0.85
Probing activation of the prokaryotic arginine transcriptional regulator using chimeric proteins. J Mol Biol (1999) 0.85
Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation (2001) 0.85
Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II). J Surg Oncol (1994) 0.85
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int (2000) 0.85
Brave or gullible: testing the concept that leaving susceptible parasites in refugia will slow the development of anthelmintic resistance. N Z Vet J (2008) 0.84
Reduced anastomotic bleeding using new sutures with a needle-suture diameter ratio of one. Surgery (1987) 0.84
Adult presentation of Caroli's syndrome treated with orthotopic liver transplantation. Am J Gastroenterol (1997) 0.83
Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant (2014) 0.83
Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators Inflamm (2000) 0.83
Managing anthelmintic resistance--use of a combination anthelmintic and leaving some lambs untreated to slow the development of resistance to ivermectin. Vet Parasitol (2011) 0.83
Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation (1993) 0.83
Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. J Ultrasound Med (1996) 0.82
Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells. Invest New Drugs (2014) 0.81
Dynamics of the free-living stages of sheep intestinal parasites on pasture in the North Island of New Zealand. 1. Patterns of seasonal development. N Z Vet J (2011) 0.81
Perioperative hyaluronic acid levels in orthotopic liver transplant recipient. Transplant Proc (1995) 0.81
Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation (1995) 0.81
Obviation of prereperfusion rinsing and decrease in preservation/reperfusion injury in liver transplantation by portal blood flushing. Transplantation (1994) 0.81
Accessory right hepatic duct stricture following liver transplantation. Transplantation (1991) 0.81
Multiple species of nematodes resistant to ivermectin and a benzimidazole-levamisole combination on a sheep farm in New Zealand. N Z Vet J (2008) 0.80
A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg (1995) 0.80
Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation. Clin Transplant (1997) 0.80
Effect of plant species on the larvae of gastrointestinal nematodes which parasitise sheep. Int J Parasitol (1998) 0.80
Splenorenal shunt closure after liver transplantation: intraoperative Doppler assessment of portal hemodynamics. Liver Transpl Surg (1997) 0.80
Preservation injury in clinical liver transplantation: incidence and effect on rejection and survival. Clin Transplant (1994) 0.80
Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transpl Surg (1997) 0.80
An in vivo assay for anti-LH-RH and anti-FSH-RH activity of inhibitory analogues of LH-RH. Endocrinology (1975) 0.80
Drench-and-shift is a high-risk practice in the absence of refugia. N Z Vet J (2009) 0.80
Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transpl Surg (1995) 0.80
Managing anthelmintic resistance: untreated adult ewes as a source of unselected parasites, and their role in reducing parasite populations. N Z Vet J (2008) 0.80
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. Transplantation (1997) 0.80
Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation (1995) 0.80
Development and spatial distribution of the free-living stages of Teladorsagia circumcincta and Trichostrongylus colubriformis on pasture: a pilot study. N Z Vet J (2011) 0.79
Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med (1994) 0.79
General guidelines for the use of tacrolimus in adult liver transplant patients. Transplantation (1996) 0.79
Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med (2000) 0.79
Transplantation of liver grafts from living donors into adults. N Engl J Med (2001) 0.79
Accidental placement of the Greenfield filter in the heart: report of two cases. J Vasc Surg (1987) 0.79
Expression of GMP-140 (P-selectin) correlates with graft viability in cold-preserved rat livers. Transplantation (2000) 0.79
Leukemia after liver transplant. Transplantation (2001) 0.79
The older liver transplant candidate: what are the limits? Liver Transpl Surg (1996) 0.79
Efficacy of oral, injectable and pour-on formulations of moxidectin against gastrointestinal nematodes in cattle in New Zealand. Vet Parasitol (2012) 0.79
Effect of topographical aspect and farm system on the population dynamics of Trichostrongylus larvae on a hill pasture. Vet Parasitol (1998) 0.78
Adult-to-adult living donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow. Transplant Proc (2007) 0.78
Differential in vivo recovery of sinusoidal endothelial cells, hepatocytes, and Kupffer cells after cold preservation and liver transplantation in rats. Transplantation (1998) 0.78